Prescient Therapeutics Ltd Cash Flow Quality Index
Prescient Therapeutics Ltd cash flow quality index. Prescient Therapeutics Ltd (PTX) has a Cash Flow Quality Index of 0.07x as of June 2013. Operating cash flow of AU$32.65K is below net income of AU$446.75K, suggesting accrual-heavy earnings not yet converted to cash. See Prescient Therapeutics Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Prescient Therapeutics Ltd (2013–2013)
Cash flow quality index of Prescient Therapeutics Ltd from 2013 to 2013. Historical Cash Flow Quality Index for Prescient Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Prescient Therapeutics Ltd to assess how comfortably operating cash covers total debt obligations.
Prescient Therapeutics Ltd Cash Flow Quality Index by Year (2013–2013)
Prescient Therapeutics Ltd cash flow quality index by year from 2013 to 2013. Year-by-year earnings quality comparison for Prescient Therapeutics Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Prescient Therapeutics Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | -0.02x | AU$-29.18K | AU$1.79 Million | — |